Sector: Health Care
The company is not available at Interactive Brokers
Adcock Ingram (JSE:AIP) is a leading South African pharmaceutical manufacturer. The Company's mission is to provide quality products that improve the health and lives of people in the markets it serves.
The Company manufactures, markets, and distributes a wide range of healthcare products and is a leading supplier to both the private and public sectors of the market.
Adcock Ingram started as a small Krugersdorp pharmacy almost 130 years ago and now ranks as the second-largest local manufacturer in the private pharmaceutical market and the second-largest supplier to the public sector in South Africa. Beyond the borders of South Africa, the Company serves markets in other African countries and also conducts operations out of India.
Adcock Ingram operates through a decentralised, autonomous operational structure that consists of four business units, each one structured to serve specific consumer needs and to meet specific regulatory requirements.
Semi-Annual values ($m)
Change (y/y)
FCF ($m)
Net Debt / Cash and Equivalents ($m)
EV / EBITDA
Potential dynamics
South African drugmaker Adcock Ingram said on Tuesday its margins would be under pressure over the next 12 months as a government-allowed price increase on regulated drugs would not be enough to cover the cost of local inflation and power cuts.
2023-02-21
Company says govt allowed price hike not enough to beat inflation
2023-02-21
South African pharmaceutical firm Adcock Ingram posted a 3% dip in annual earnings on Wednesday as pandemic-related restrictions helped people avoid flu in the winter months of June and July, hurting sales of related drugs.
2021-08-25
South African drugmaker Adcock Ingram Holdings scrapped its dividend on Wednesday, warning the coronavirus crisis could wipe out revenue growth in its new financial year.
2020-08-26
* Bidvest shares down 0.07 pct to 211.46 rand at 1350 GMT (Recasts with CEO designate)
2019-03-04
